다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

BVS

Bioventus (BVS)

Bioventus Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BVS

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/07	20:36	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BVS	Bioventus Inc
2024/05/07	20:33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BVS	Bioventus Inc
2024/05/07	20:00	GlobeNewswire Inc.	Bioventus Reports First Quarter Financial Results	NASDAQ:BVS	Bioventus Inc
2024/04/29	20:30	GlobeNewswire Inc.	Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024	NASDAQ:BVS	Bioventus Inc
2024/03/12	20:30	GlobeNewswire Inc.	Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:BVS	Bioventus Inc
2024/03/04	22:00	GlobeNewswire Inc.	Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024	NASDAQ:BVS	Bioventus Inc
2024/02/07	06:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BVS	Bioventus Inc
2024/01/23	06:07	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BVS	Bioventus Inc
2024/01/19	22:27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BVS	Bioventus Inc
2024/01/19	06:15	GlobeNewswire Inc.	Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility	NASDAQ:BVS	Bioventus Inc
2024/01/13	07:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BVS	Bioventus Inc
2024/01/13	06:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BVS	Bioventus Inc
2024/01/13	06:39	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:BVS	Bioventus Inc
2024/01/13	06:15	GlobeNewswire Inc.	Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole	NASDAQ:BVS	Bioventus Inc
2024/01/09	22:55	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BVS	Bioventus Inc
2023/12/21	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BVS	Bioventus Inc
2023/12/20	06:30	GlobeNewswire Inc.	Bioventus Names Robert Claypoole as President and Chief Executive Officer	NASDAQ:BVS	Bioventus Inc
2023/12/06	22:00	GlobeNewswire Inc.	Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis	NASDAQ:BVS	Bioventus Inc
2023/11/07	21:40	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BVS	Bioventus Inc
2023/11/07	21:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BVS	Bioventus Inc
2023/11/07	21:00	GlobeNewswire Inc.	Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance	NASDAQ:BVS	Bioventus Inc
2023/10/31	20:00	GlobeNewswire Inc.	Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023	NASDAQ:BVS	Bioventus Inc
2023/09/20	10:52	GlobeNewswire Inc.	Bioventus to Present at the Cantor Global Healthcare Conference	NASDAQ:BVS	Bioventus Inc
2023/09/07	05:30	GlobeNewswire Inc.	Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference	NASDAQ:BVS	Bioventus Inc
2023/08/08	21:42	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BVS	Bioventus Inc
2023/08/08	21:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BVS	Bioventus Inc
2023/08/08	20:30	GlobeNewswire Inc.	Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance	NASDAQ:BVS	Bioventus Inc
2023/08/04	21:30	GlobeNewswire Inc.	Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference	NASDAQ:BVS	Bioventus Inc
2023/08/02	06:35	GlobeNewswire Inc.	Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023	NASDAQ:BVS	Bioventus Inc
2023/06/23	05:57	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BVS	Bioventus Inc

검색 관련기사 보기:NASDAQ:BVS

1 2 3 4 5 6 7 다음 >>

Pharmaceutical Commerce

Vontobel Financial Produ...

Franklin Conservative Gr...

High Dividend Equity Por...

FlexShares International...

UBS ETF MSCI Australia U...

JPM ESG Green Social & S...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관